The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 13, 2021
Filed:
Dec. 05, 2016
Applicants:
Merck Patent Gmbh, Darmstadt, DE;
Pfizer Inc., New York, NY (US);
Inventors:
Gianluca Rinaldi, Monterotondo, IT;
Alessandra Del Rio, Rome, IT;
Silvia Fratar-Cangeli, Ceprano, IT;
Senta Voss, Mainz, DE;
Markus Weigandt, Mannheim, DE;
Assignees:
MERCK PATENT GMBH, Darmstadt, DE;
PFIZER INC., New York, NY (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C07K 16/28 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39591 (2013.01); C07K 16/2827 (2013.01); A61K 2039/54 (2013.01); C07K 2317/21 (2013.01); C07K 2317/76 (2013.01);
Abstract
The present invention relates to a novel anti-PD-L1 antibody formulation. In particular, the invention relates to an aqueous pharmaceutical formulation of the anti-PD-L1 antibody Avelumab.
Rinaldi, Gianluca. (2021). Aqueous pharmaceutical formulation comprising anti-pd-l1 antibody avelumab (U.S. Patent No. 11058769). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11058769
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile